HbA1c News and Research

RSS

Canola bread diet experiences reduction in blood glucose levels and LDL cholesterol

Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with Type 2 diabetes.

16 Jun 2014

Improved glycemic control can slow progression of ESRD in type 1 diabetic people

People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.

6 Jun 2014

NCOA brings innovative online support program to help people manage type 2 diabetes

Under a unique collaboration, the National Council on Aging with support from the Bristol-Myers Squibb Foundation and WellPoint are—for the first time—bringing a proven and affordable face-to-face and online support program to help people manage their Type 2 diabetes.

6 Jun 2014

Glycaemic control crucial in first years after diabetes diagnosis

The largest deterioration in glycaemic control among patients with newly diagnosed Type 2 diabetes occurs in the first 2 years after diagnosis, research shows.

5 Jun 2014

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Transition Therapeutics Inc. today announced the dosing of the first patient in a Phase 2 clinical study of TT-401 (LY2944876), a drug candidate for the treatment of type 2 diabetes.

15 May 2014

Isis Pharmaceuticals reports positive data from ISIS-GCGRRx Phase 2 study in patients with type 2 diabetes

Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.

14 May 2014

Teaching people to self-manage diabetes leads to better results

Teaching people with diabetes how to control their blood glucose levels helps them achieve better results, finds a new study in Ethnicity and Disease. Surprisingly, providing intensive training to physicians of diabetes patients did not help patients achieve blood glucose control.

9 May 2014

Alarming increases in diabetes and pre-diabetes cases in the U.S.

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics and the elderly.

16 Apr 2014

New edition of RADAR includes review of glycopyrronium for COPD treatment

NPS MedicineWise has published a new edition of RADAR, including a review of glycopyrronium (Seebri Breezhaler), a new medicine for the treatment of chronic obstructive pulmonary disease (COPD).

10 Apr 2014

Bariatric surgery patients report better quality of life

A study by Cleveland Clinic researchers shows bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients, enabling nearly all surgical patients to be free of insulin and many to be free of all diabetic medications three years after surgery.

31 Mar 2014

Kamada initiates Phase 2/3 clinical trial of Glassia to treat pediatric patients with T1D

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the initiation of a Phase 2/3 clinical trial of Glassia®, the Company's proprietary human Alpha-1 Antitrypsin (AAT), to treat newly diagnosed pediatric patients with type 1 diabetes (T1D).

5 Mar 2014

ADA screening guidelines may lead to missed diagnoses of type 2 diabetes in children, says study

New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.

12 Feb 2014

Trinidad and Tobago, Johns Hopkins Medicine celebrate achievements of Diabetes Outreach Program

Members of the Trinidad and Tobago Health Science Initiative’s Diabetes Outreach Program joined the country’s Minister of Health Fuad Khan Tuesday in Port of Spain to celebrate the program’s achievements in fighting diabetes in Trinidad and Tobago.

30 Jan 2014

Copenhagen researchers boost self-efficacy of diabetic patients through motivational health coaching

By means of so-called health coaching, researchers at the University of Copenhagen have helped a large group of diabetics to markedly improve their oral health.

27 Jan 2014

Diabetes research underlines the importance of achieving blood sugar goals

Diabetes research led by the University of Exeter Medical School has underlined the importance of people with diabetes achieving their blood sugar goals, to reduce the risk of complications.

17 Jan 2014

Research findings provide insights into risks associated with isolated mild hyperglycemia

Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.

15 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

StemGenex offers stem cell treatment studies to patients diagnosed with diabetes, neurological diseases

According to The American Diabetes Association there are over 25 million people in the US living with diabetes. These patients are suffering from complications such as heart disease, stroke, high blood pressure, blindness, kidney disease, neuropathy and amputation.

8 Jan 2014

EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health

EKF, will be exhibiting two newly introduced point-of-care testing analyzers for rapid assessment of diabetes and related conditions.

From EKF Diagnostics 8 Jan 2014

Linagliptin as monotherapy or in combination with metformin reduces blood glucose levels in T2D patients

Boehringer Ingelheim and Eli Lilly and Company today announced new data from a Phase IV study evaluating linagliptin (5 mg) as monotherapy and in combination with metformin (1500 or 2000 mg) in treatment-naive adults with newly diagnosed (<12 months) uncontrolled Type 2 Diabetes.

4 Dec 2013